PMID- 30532100
OWN - NLM
STAT- MEDLINE
DCOM- 20190911
LR  - 20190911
IS  - 0016-3813 (Print)
IS  - 0016-3813 (Linking)
VI  - 154
IP  - 6
DP  - 2018
TI  - [Péptidos antimicrobianos, una alternativa prometedora para el tratamiento de 
      enfermedades infecciosas].
PG  - 681-688
LID - 10.24875/GMM.18003445 [doi]
AB  - Microorganisms that cause diseases in humans are constantly evolving, which 
      represents a challenge in the search for effective treatments against them. Even 
      when currently there are several pharmacological alternatives available, sometimes 
      they are inefficient for the control of infectious diseases, especially because 
      pathogens have generated multiple resistance mechanisms against them. Antimicrobial 
      peptides have been described in many species of organisms, from fungi, plants and 
      insects to humans; currently, there are molecules that appear as a solution that can 
      be effective in modern therapeutics. The advantage of these natural peptides lies in 
      that they have been evolving almost the same amount of time than the species that 
      produce them and their effect on the control of microorganisms is highly 
      significant; some of these molecules are isolated from living organisms, others are 
      starting to be produced by synthetic methods, which allows having access to an 
      endless number of peptides with diverse therapeutic activities.
CI  - Copyright: © 2018 SecretarÍa de Salud.
FAU - Samael Olascoaga-Del, Angel Kevin
AU  - Samael Olascoaga-Del AK
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
FAU - Sánchez-Evangelista, Grecia
AU  - Sánchez-Evangelista G
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
FAU - Carmona-Navarrete, Israel
AU  - Carmona-Navarrete I
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
FAU - Galicia-Sánchez, María Del Carmen
AU  - Galicia-Sánchez MDC
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
FAU - Gómez-Luna, Angélica
AU  - Gómez-Luna A
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
FAU - Islas-Arrollo, Susan Janneth
AU  - Islas-Arrollo SJ
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
FAU - Castañeda-Sánchez, Jorge Ismael
AU  - Castañeda-Sánchez JI
AD  - Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México, México.
LA  - spa
PT  - Journal Article
PT  - Review
PL  - Mexico
TA  - Gac Med Mex
JT  - Gaceta medica de Mexico
JID - 0010333
RN  - 0 (Anti-Infective Agents)
RN  - 0 (Peptides)
SB  - IM
MH  - Anti-Infective Agents/*administration & dosage/chemical synthesis/isolation & 
      purification
MH  - Communicable Diseases/*drug therapy/microbiology
MH  - Drug Resistance, Microbial
MH  - Drug Resistance, Multiple
MH  - Humans
MH  - Peptides/*administration & dosage/chemical synthesis/isolation & purification
OTO - NOTNLM
OT  - *Antimicrobial peptides
OT  - *Drug resistance
OT  - *Enfermedades infecciosas
OT  - *Infectious diseases
OT  - *Péptidos antimicrobianos
OT  - *Resistencia a fármacos
EDAT- 2018/12/12 06:00
MHDA- 2019/09/12 06:00
CRDT- 2018/12/12 06:00
PHST- 2018/12/12 06:00 [entrez]
PHST- 2018/12/12 06:00 [pubmed]
PHST- 2019/09/12 06:00 [medline]
AID - j154/6/681 [pii]
AID - 10.24875/GMM.18003445 [doi]
PST - ppublish
SO  - Gac Med Mex. 2018;154(6):681-688. doi: 10.24875/GMM.18003445.

PMID- 22524110
OWN - NLM
STAT- MEDLINE
DCOM- 20130516
LR  - 20120424
IS  - 0535-5133 (Print)
IS  - 0535-5133 (Linking)
VI  - 53
IP  - 1
DP  - 2012 Mar
TI  - [Antimicrobial peptides: a potential arsenal against HIV infection].
PG  - 71-83
AB  - HIV (human immunodeficiency virus) infection is today a very important health issue 
      worldwide, which demands new ways and strategies for its prevention and treatment. 
      Several studies on the innate immunity against HIV infection have shown that 
      antimicrobial peptides are associated with increased resistance to infection. In the 
      present review, we briefly summarize the major characteristics of antimicrobial 
      peptides from human and several species of plants, amphibians, insects and other 
      animal species that have significant potential to be used as therapeutic or 
      prophylactic agents. The mechanisms of infection inhibition and viral replication 
      blockade are also described in the context of the biology of infection.
FAU - Castañeda-Delgado, Julio Enrique
AU  - Castañeda-Delgado JE
AD  - Unidad de Investigación Médica-Zacatecas, IMSS, Zacatecas, México.
FAU - Cervantes-Villagrana, Alberto Rafael
AU  - Cervantes-Villagrana AR
FAU - Rivas-Santiago, Bruno
AU  - Rivas-Santiago B
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Péptidos antimicrobianos: un probable arsenal contra la infección por VIH.
PL  - Venezuela
TA  - Invest Clin
JT  - Investigacion clinica
JID - 0421531
RN  - 0 (Anti-HIV Agents)
RN  - 0 (Antimicrobial Cationic Peptides)
SB  - IM
MH  - Animals
MH  - Anti-HIV Agents/isolation & purification/pharmacology/*therapeutic use
MH  - Antimicrobial Cationic Peptides/isolation & purification/pharmacology/*therapeutic 
      use
MH  - Drug Discovery
MH  - Drug Evaluation, Preclinical
MH  - HIV/drug effects
MH  - HIV Infections/*drug therapy
MH  - Humans
MH  - Invertebrates/chemistry
MH  - Plants/chemistry
MH  - Species Specificity
MH  - Vertebrates/metabolism
MH  - Virus Replication/drug effects
EDAT- 2012/04/25 06:00
MHDA- 2013/05/17 06:00
CRDT- 2012/04/25 06:00
PHST- 2012/04/25 06:00 [entrez]
PHST- 2012/04/25 06:00 [pubmed]
PHST- 2013/05/17 06:00 [medline]
PST - ppublish
SO  - Invest Clin. 2012 Mar;53(1):71-83.

PMID- 23437545
OWN - NLM
STAT- MEDLINE
DCOM- 20130401
LR  - 20191210
IS  - 0375-0760 (Print)
IS  - 0375-0760 (Linking)
VI  - 62
IP  - 3
DP  - 2010 Sep-Dec
TI  - [Enzymatic immunoassays for the detection of infectious agents or their products: 
      presentation of some designs and applications].
PG  - 167-79
AB  - This paper assessed the impact of the immunoenzymatic assays on the field of the 
      immunochemistry-based analytics for the last 40 years, and on the detection of 
      infectious agents or the products related to their presence and/or pathogenic 
      activity. It also addressed some designs and formats of these immunoassays from 
      electrochemical methods of detection, assays to determine proteolytic microbial 
      activity and their inhibitors as possible therapeutical targets, more sensitive 
      direct triple antibody systems, alternative enzymatic activity detectors, assays for 
      viral serology of minimal determinations to competitive assays for evaluation of 
      vaccinal candidate effectiveness based on selected peptide combinations. Finally, it 
      provided a rapid overview of the near future of this type of immunoassays in the 
      light of the emerging detection analytical technologies.
FAU - Otero González, Anselmo J
AU  - Otero González AJ
AD  - Laboratorio de Immunoanalitica y péptidos antimicrobianos, Facultad De Biología, 
      Centro De Estudios de Proteínas, Universidad de La Habana, Cuba. 
      aoterog@infomed.sld.cu
LA  - spa
PT  - Journal Article
PT  - Review
TT  - Inmunoensayos enzimáticos para detectar agentes infecciosos o sus productos: algunos 
      diseños y aplicaciones.
PL  - Cuba
TA  - Rev Cubana Med Trop
JT  - Revista cubana de medicina tropical
JID - 0074364
SB  - IM
MH  - Humans
MH  - Immunoenzyme Techniques/*methods
MH  - Infections/*microbiology
EDAT- 2010/09/01 00:00
MHDA- 2013/04/02 06:00
CRDT- 2013/02/27 06:00
PHST- 2013/02/27 06:00 [entrez]
PHST- 2010/09/01 00:00 [pubmed]
PHST- 2013/04/02 06:00 [medline]
PST - ppublish
SO  - Rev Cubana Med Trop. 2010 Sep-Dec;62(3):167-79.

PMID- 33405536
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210114
IS  - 2373-9878 (Electronic)
IS  - 2373-9878 (Linking)
VI  - 5
IP  - 11
DP  - 2019 Nov 11
TI  - 3D Printing of Antimicrobial Alginate/Bacterial-Cellulose Composite Hydrogels by 
      Incorporating Copper Nanostructures.
PG  - 6290-6299
LID - 10.1021/acsbiomaterials.9b01048 [doi]
AB  - Novel antimicrobial 3D-printed alginate/bacterial-cellulose hydrogels with in 
      situ-synthesized copper nanostructures were developed having improved printability. 
      Prior to 3D printing, two methods were tested for the development of the alginate 
      hydrogels: (a) ionic cross-linking with calcium ions followed by ion exchange with 
      copper ions (method A) and (b) ionic cross-linking with copper ions (method B). A 
      solution containing sodium borohydride, used as a reducing agent, was subsequently 
      added to the hydrogels, producing in situ clusters of copper nanoparticles embedded 
      in the alginate hydrogel matrix. The method used and concentrations of copper and 
      the reducing agent were found to affect the stability of the alginate/copper 
      hydrogels, with method A producing more stable materials. By increasing the alginate 
      concentration from 1 to 4 wt % and by using method A, 
      alginate/bacterial-cellulose/copper hydrogel structures were 3D-printed having 
      excellent printability as compared with pure alginate hydrogels. It is noteworthy 
      that after reduction with sodium borohydride, the 3D structures presented 
      antimicrobial behavior against Escherichia coli and Staphylococcus aureus strains. 
      Our results introduce a simple route for the production of alginate/cellulose inks 
      with improved behavior toward antimicrobial 3D-printed materials.
FAU - Gutierrez, Elena
AU  - Gutierrez E
FAU - Burdiles, Patricio A
AU  - Burdiles PA
FAU - Quero, Franck
AU  - Quero F
AUID- ORCID: 0000-0002-5535-5242
FAU - Palma, Patricia
AU  - Palma P
AD  - Laboratorio de Microbiología Oral, Área Péptidos y Compuestos Antimicrobianos, 
      Facultad de Odontología, Universidad de Chile, Olivos 943, 8380544 Independencia, 
      Chile.
FAU - Olate-Moya, Felipe
AU  - Olate-Moya F
AUID- ORCID: 0000-0002-2000-0708
FAU - Palza, Humberto
AU  - Palza H
AUID- ORCID: 0000-0001-5246-6791
LA  - eng
PT  - Journal Article
DEP - 20191023
PL  - United States
TA  - ACS Biomater Sci Eng
JT  - ACS biomaterials science & engineering
JID - 101654670
SB  - IM
OTO - NOTNLM
OT  - 3D printing
OT  - active hydrogels
OT  - antimicrobial materials
OT  - bacterial cellulose
OT  - copper
EDAT- 2019/11/11 00:00
MHDA- 2019/11/11 00:01
CRDT- 2021/01/06 17:10
PHST- 2021/01/06 17:10 [entrez]
PHST- 2019/11/11 00:00 [pubmed]
PHST- 2019/11/11 00:01 [medline]
AID - 10.1021/acsbiomaterials.9b01048 [doi]
PST - ppublish
SO  - ACS Biomater Sci Eng. 2019 Nov 11;5(11):6290-6299. doi: 
      10.1021/acsbiomaterials.9b01048. Epub 2019 Oct 23.

PMID- 16555536
OWN - NLM
STAT- MEDLINE
DCOM- 20060728
LR  - 20191210
IS  - 0036-3634 (Print)
IS  - 0036-3634 (Linking)
VI  - 48
IP  - 1
DP  - 2006 Jan-Feb
TI  - [Antimicrobial peptides in the innate immunity of infectious diseases].
PG  - 62-71
AB  - Antimicrobial peptides are key effector molecules of the innate immune response. 
      Generally, they are formed by 14-45 aminoacid residues; most of them have a positive 
      charge and amphipathic properties. These peptides are secreted mainly by epithelial 
      cells, neutrophils and macrophages. Based on sequence translation using computer 
      programs, more than 800 types of antimicrobial peptides have been described in 
      plants and animals. Antimicrobial peptides are divided according to the position of 
      disulfide bridges and structural conformation. Defensins are the most studied 
      antimicrobial peptides and are classified into alpha-defensins and beta-defensins. 
      Many of these defensins can be induced by proinflammatory cytokines and pathogen 
      associated molecules. Moreover, they have been shown to partake in the 
      immunopathology of several diseases. The main role of antimicrobial peptides is the 
      direct lysis of microbes. These peptides also have chemotactic properties, which may 
      modulate the immune response, serving as a bridge between the innate and adaptive 
      immune responses. Currently, several studies are exploring the possibility of using 
      these antimicrobial peptides as new therapeutic agents against different infectious 
      diseases.
FAU - Rivas-Santiago, Bruno
AU  - Rivas-Santiago B
AD  - Departamento de Investigación en Microbiología, Instituto Nacional de Enfermedades 
      Respiratorias (INER), México. btrivas@iner.gob.mx
FAU - Sada, Eduardo
AU  - Sada E
FAU - Hernández-Pando, Rogelio
AU  - Hernández-Pando R
FAU - Tsutsumi, Víctor
AU  - Tsutsumi V
LA  - spa
PT  - Journal Article
PT  - Review
TT  - Péptidos antimicrobianos en la inmunidad innata de enfermedades infecciosas.
PL  - Mexico
TA  - Salud Publica Mex
JT  - Salud publica de Mexico
JID - 0404371
RN  - 0 (Antimicrobial Cationic Peptides)
RN  - 0 (Defensins)
SB  - IM
MH  - Animals
MH  - Antimicrobial Cationic Peptides/*immunology
MH  - Defensins/immunology
MH  - Humans
MH  - *Immunity, Innate
MH  - Infections/*immunology
RF  - 50
EDAT- 2006/03/25 09:00
MHDA- 2006/07/29 09:00
CRDT- 2006/03/25 09:00
PHST- 2006/03/25 09:00 [pubmed]
PHST- 2006/07/29 09:00 [medline]
PHST- 2006/03/25 09:00 [entrez]
AID - S0036-36342006000100010 [pii]
AID - 10.1590/s0036-36342006000100010 [doi]
PST - ppublish
SO  - Salud Publica Mex. 2006 Jan-Feb;48(1):62-71. doi: 10.1590/s0036-36342006000100010.

PMID- 27063608
OWN - NLM
STAT- MEDLINE
DCOM- 20160818
LR  - 20191210
IS  - 0006-3002 (Print)
IS  - 0006-3002 (Linking)
VI  - 1858
IP  - 7 Pt A
DP  - 2016 Jul
TI  - Structural and functional evaluation of the palindromic alanine-rich antimicrobial 
      peptide Pa-MAP2.
PG  - 1488-98
LID - S0005-2736(16)30129-8 [pii]
LID - 10.1016/j.bbamem.2016.04.003 [doi]
AB  - Recently, several peptides have been studied regarding the defence process against 
      pathogenic microorganisms, which are able to act against different targets, with the 
      purpose of developing novel bioactive compounds. The present work focuses on the 
      structural and functional evaluation of the palindromic antimicrobial peptide 
      Pa-MAP2, designed based on the peptide Pa-MAP from Pleuronectes americanus. For a 
      better structural understanding, molecular modelling analyses were carried out, 
      together with molecular dynamics and circular dichroism, in different media. 
      Antibacterial activity against Gram-negative and positive bacteria was evaluated, as 
      well as cytotoxicity against human erythrocytes, RAW 264.7, Vero and L6 cells. In 
      silico docking experiments, lipid vesicle studies, and atomic force microscopy (AFM) 
      imaging were carried out to explore the activity of the peptide. In vivo studies on 
      infected mice were also done. The palindromic primary sequence favoured an α-helix 
      structure that was pH dependent, only present on alkaline environment, with dynamic 
      N- and C-terminals that are stabilized in anionic media. Pa-MAP2 only showed 
      activity against Gram-negative bacteria, with a MIC of 3.2 μM, and without any 
      cytotoxic effect. In silico, lipid vesicles and AFM studies confirm the preference 
      for anionic lipids (POPG, POPS, DPPE, DPPG and LPS), with the positively charged 
      lysine residues being essential for the initial electrostatic interaction. In vivo 
      studies showed that Pa-MAP2 increases to 100% the survival rate of mice infected 
      with Escherichia coli. Data here reported indicated that palindromic Pa-MAP2 could 
      be an alternative candidate for use in therapeutics against Gram-negative bacterial 
      infections.
CI  - Copyright © 2016. Published by Elsevier B.V.
FAU - Migliolo, Ludovico
AU  - Migliolo L
AD  - Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências 
      Genômicas e Biotecnologia, UCB, Brasília, DF, Brazil; S-inova Biotech, Programa de 
      Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, 
      Brazil.
FAU - Felício, Mário R
AU  - Felício MR
AD  - Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 
      Lisbon, Portugal.
FAU - Cardoso, Marlon H
AU  - Cardoso MH
AD  - Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências 
      Genômicas e Biotecnologia, UCB, Brasília, DF, Brazil; S-inova Biotech, Programa de 
      Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, 
      Brazil; Programa de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, 
      Universidade de Brasília, Brasília, DF, Brazil.
FAU - Silva, Osmar N
AU  - Silva ON
AD  - Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências 
      Genômicas e Biotecnologia, UCB, Brasília, DF, Brazil.
FAU - Xavier, Mary-Ann E
AU  - Xavier MA
AD  - Departamento de Biologia Celular, Laboratório de Biofísica, UnB, Brasília, DF, 
      Brazil.
FAU - Nolasco, Diego O
AU  - Nolasco DO
AD  - Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências 
      Genômicas e Biotecnologia, UCB, Brasília, DF, Brazil; Research Laboratory of 
      Electronics, Massachusetts Institute of Technology - MIT, Cambridge, MA, United 
      States.
FAU - de Oliveira, Adeliana Silva
AU  - de Oliveira AS
AD  - Instituto de Salud Global, CRESIB - Hospital Clinic, Universitat de Barcelona, 
      Barcelona, Spain.
FAU - Roca-Subira, Ignasi
AU  - Roca-Subira I
AD  - Instituto de Salud Global, CRESIB - Hospital Clinic, Universitat de Barcelona, 
      Barcelona, Spain.
FAU - Vila Estape, Jordi
AU  - Vila Estape J
AD  - Instituto de Salud Global, CRESIB - Hospital Clinic, Universitat de Barcelona, 
      Barcelona, Spain.
FAU - Teixeira, Leandro D
AU  - Teixeira LD
AD  - Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências 
      Genômicas e Biotecnologia, UCB, Brasília, DF, Brazil.
FAU - Freitas, Sonia M
AU  - Freitas SM
AD  - Departamento de Biologia Celular, Laboratório de Biofísica, UnB, Brasília, DF, 
      Brazil.
FAU - Otero-Gonzalez, Anselmo J
AU  - Otero-Gonzalez AJ
AD  - Laboratorio de Immunoanalitica y péptidos antimicrobianos, Faculdad de Biología, 
      Centro de estudios de Proteínas, Universidad de La Habana, Cuba.
FAU - Gonçalves, Sónia
AU  - Gonçalves S
AD  - Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 
      Lisbon, Portugal.
FAU - Santos, Nuno C
AU  - Santos NC
AD  - Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 
      Lisbon, Portugal.
FAU - Franco, Octavio L
AU  - Franco OL
AD  - Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências 
      Genômicas e Biotecnologia, UCB, Brasília, DF, Brazil; S-inova Biotech, Programa de 
      Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, 
      Brazil; Programa de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, 
      Universidade de Brasília, Brasília, DF, Brazil. Electronic address: 
      ocfranco@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160408
PL  - Netherlands
TA  - Biochim Biophys Acta
JT  - Biochimica et biophysica acta
JID - 0217513
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Antimicrobial Cationic Peptides)
RN  - 0 (Lipopolysaccharides)
RN  - 0 (Peptidomimetics)
RN  - 0 (Phosphatidylcholines)
RN  - 0 (Phosphatidylglycerols)
RN  - 0 (Phosphatidylserines)
RN  - 0 (Unilamellar Liposomes)
RN  - 40290-44-6 (1-palmitoyl-2-oleoylglycero-3-phosphoserine)
RN  - 81490-05-3 (1-palmitoyl-2-oleoylglycero-3-phosphoglycerol)
RN  - 97C5T2UQ7J (Cholesterol)
RN  - OF5P57N2ZX (Alanine)
RN  - TE895536Y5 (1-palmitoyl-2-oleoylphosphatidylcholine)
SB  - IM
MH  - Alanine/chemistry
MH  - Amino Acid Sequence
MH  - Animals
MH  - Anti-Bacterial Agents/chemical synthesis/*chemistry/pharmacology
MH  - Antimicrobial Cationic Peptides/*chemistry/isolation & purification
MH  - Cell Survival/drug effects
MH  - Chlorocebus aethiops
MH  - Cholesterol/chemistry
MH  - Erythrocytes/drug effects
MH  - Escherichia coli/drug effects/growth & development
MH  - Escherichia coli Infections/*drug therapy/microbiology/mortality
MH  - Flounder/metabolism
MH  - Humans
MH  - Lipopolysaccharides/chemistry
MH  - Mice
MH  - Molecular Dynamics Simulation
MH  - Molecular Sequence Data
MH  - Peptidomimetics/chemical synthesis/*chemistry/pharmacology
MH  - Phosphatidylcholines/chemistry
MH  - Phosphatidylglycerols/chemistry
MH  - Phosphatidylserines/chemistry
MH  - Protein Structure, Secondary
MH  - Protein Structure, Tertiary
MH  - Survival Analysis
MH  - Unilamellar Liposomes/chemistry
MH  - Vero Cells
OTO - NOTNLM
OT  - Molecular dynamics
OT  - Pa-MAP2
OT  - Pleuronectes americanus
OT  - Secondary structure
OT  - Synthetic palindromic peptide
EDAT- 2016/04/12 06:00
MHDA- 2016/08/19 06:00
CRDT- 2016/04/12 06:00
PHST- 2015/12/07 00:00 [received]
PHST- 2016/03/22 00:00 [revised]
PHST- 2016/04/05 00:00 [accepted]
PHST- 2016/04/12 06:00 [entrez]
PHST- 2016/04/12 06:00 [pubmed]
PHST- 2016/08/19 06:00 [medline]
AID - S0005-2736(16)30129-8 [pii]
AID - 10.1016/j.bbamem.2016.04.003 [doi]
PST - ppublish
SO  - Biochim Biophys Acta. 2016 Jul;1858(7 Pt A):1488-98. doi: 
      10.1016/j.bbamem.2016.04.003. Epub 2016 Apr 8.

PMID- 22367403
OWN - NLM
STAT- MEDLINE
DCOM- 20120710
LR  - 20211021
IS  - 1432-0991 (Electronic)
IS  - 0343-8651 (Linking)
VI  - 64
IP  - 5
DP  - 2012 May
TI  - Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal 
      proteins from the littoral mollusk Cenchritis muricatus.
PG  - 501-5
LID - 10.1007/s00284-012-0096-5 [doi]
AB  - Marine organisms represent approximately half of the world's biodiversity by virtue 
      of the sea being an immense reservoir of bioactive molecules. Here, antimicrobial 
      crude extract activities of different marine invertebrates from the Caribbean Sea 
      were evaluated. One of the most active, crude extracts was that marine snail 
      Cenchritis muricatus, it was capable of totally inhibiting the development of 
      Staphylococcus aureus and also showed a growth inhibition of 95.9% in Escherichia 
      coli. Aiming to isolate molecules that confirm antimicrobial activity, the crude 
      extract was purified by reversed-phase HPLC C-18 chromatography. Thereafter, one of 
      the obtained fractions preserved this antibacterial activity. Furthermore, SDS-PAGE 
      analysis (15%) showed the presence of two proteins of molecular masses with 
      approximately 10 and 15 kDa, respectively. The first 19 amino acids of both proteins 
      were sequenced by using Edman degradation, yielding unidentified primary structures 
      compared against sequences deposited at NCBI databank. This is the first report of 
      antibacterial proteins isolated from the mollusk Cenchritis muricatus and these 
      proteins could be used as antibiotic alternatives in the aquacultural industry, as 
      well as in agricultural or biomedical research.
FAU - López-Abarrategui, Carlos
AU  - López-Abarrategui C
AD  - Laboratoriode Inmunoanalìtica y Péptidos Antimicrobianos, Centro de Estudios de 
      Proteínas, Universidad de La Habana, La Habana, Cuba.
FAU - Alba, Annia
AU  - Alba A
FAU - Lima, Loiane A
AU  - Lima LA
FAU - Maria-Neto, Simone
AU  - Maria-Neto S
FAU - Vasconcelos, Ilka M
AU  - Vasconcelos IM
FAU - Oliveira, Jose T A
AU  - Oliveira JT
FAU - Dias, Simoni C
AU  - Dias SC
FAU - Otero-Gonzalez, Anselmo J
AU  - Otero-Gonzalez AJ
FAU - Franco, Octavio L
AU  - Franco OL
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120226
PL  - United States
TA  - Curr Microbiol
JT  - Current microbiology
JID - 7808448
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Proteins)
SB  - IM
MH  - Amino Acid Sequence
MH  - Animals
MH  - Anti-Bacterial Agents/chemistry/metabolism/*pharmacology
MH  - Caribbean Region
MH  - Drug Evaluation, Preclinical
MH  - Escherichia coli/*drug effects/growth & development
MH  - Microbial Sensitivity Tests
MH  - Molecular Sequence Data
MH  - Mollusca/*chemistry/classification/metabolism
MH  - Proteins/chemistry/metabolism/*pharmacology
MH  - Staphylococcus aureus/*drug effects/growth & development
EDAT- 2012/03/01 06:00
MHDA- 2012/07/11 06:00
CRDT- 2012/02/28 06:00
PHST- 2011/11/29 00:00 [received]
PHST- 2012/02/03 00:00 [accepted]
PHST- 2012/02/28 06:00 [entrez]
PHST- 2012/03/01 06:00 [pubmed]
PHST- 2012/07/11 06:00 [medline]
AID - 10.1007/s00284-012-0096-5 [doi]
PST - ppublish
SO  - Curr Microbiol. 2012 May;64(5):501-5. doi: 10.1007/s00284-012-0096-5. Epub 2012 Feb 
      26.

PMID- 19685832
OWN - NLM
STAT- MEDLINE
DCOM- 20090930
LR  - 20091111
IS  - 0016-3813 (Print)
IS  - 0016-3813 (Linking)
VI  - 145
IP  - 3
DP  - 2009 May-Jun
TI  - [Antimicrobial peptide elicitors: a potential strategy against infections].
PG  - 241-3
AB  - The drawbacks associated with antibiotic-based treatment of infectious diseases 
      including an increase in multidrug-resistant strains and adverse reactions have lead 
      to the search of antimicrobial peptide elicitors (APE), harmless substances that 
      boost an overexpression of innate immunity genes. Knowledge on innate immunity 
      activation pathways and their interactions with adaptive immunity would lead to more 
      effective, faster and safer APE-based treatments to battle infections which still 
      are a common public health problem worldwide.
FAU - Prado-Montes de Oca, Ernesto
AU  - Prado-Montes de Oca E
AD  - Laboratorio de Biología Molecular, Unidad Sureste de Servicios Tecnológicos, Centro 
      de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, A.C., 
      CONACYT Mérida, Yucatán, México. eprado@ciatej.net.mx
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
TT  - Elicitores de péptidos antimicrobianos: estrategia potencial contra infecciones.
PL  - Mexico
TA  - Gac Med Mex
JT  - Gaceta medica de Mexico
JID - 0010333
RN  - 0 (Antimicrobial Cationic Peptides)
SB  - IM
MH  - Antimicrobial Cationic Peptides/*therapeutic use
MH  - Bacterial Infections/*drug therapy/*immunology
MH  - Humans
EDAT- 2009/08/19 09:00
MHDA- 2009/10/01 06:00
CRDT- 2009/08/19 09:00
PHST- 2009/08/19 09:00 [entrez]
PHST- 2009/08/19 09:00 [pubmed]
PHST- 2009/10/01 06:00 [medline]
PST - ppublish
SO  - Gac Med Mex. 2009 May-Jun;145(3):241-3.
